Maravai Shares Q4 2025 Results in Upcoming Investor Call

Maravai LifeSciences is set to release its fourth‑quarter and full‑year financial statements for 2025 after the market closes on Wednesday, February 25, 2026. The company will host a conference call and webcast at 2:00 p. m. PT (5:00 p. m. ET) on the same day to discuss the results. Investors can join the call by dialing 1‑800‑343‑4136 or 1‑203‑518‑9843 and entering the Conference ID “MARAVAI. ” The session will also be streamed live or available as an archive on Maravai’s investor website at https://investors. maravai. com.Maravai supplies essential reagents and services that help scientists develop drugs, diagnostics, vaccines, and cell‑and‑gene therapies. Its products are widely used by leading biopharmaceutical and diagnostic companies around the world. The upcoming announcement will give stakeholders insight into how Maravai’s innovations are driving progress in medical research and commercializing new therapies.